Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Avvisati

Showing results (111-120 of 145) with videos related to

Pageof 15
Sort By:
Blood|July 15, 1993
Polyclonal hematopoietic reconstitution in leukemia patients at remission after suppression of specific gene rearrangementsF Lo Coco, P G Pelicci, F D'Adamo, et al.
The New England Journal of Medicine|May 17, 1990
Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapyF Mandelli, G Avvisati, S Amadori, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 1998
The role of all-trans-retinoic acid (ATRA) treatment in newly-diagnosed acute promyelocytic leukemia patients aged > 60 yearsR Latagliata, G Avvisati, F Lo Coco, et al.
Haematologica|October 17, 2001
High dose of idarubicin-based regimen for diffuse large cell AIDS-related non-Hodgkin's lymphoma patients: a pilot studyR Gastaldi, P Martino, G Gentile, et al.
Haematologica|March 1, 1993
Recombinant human erythropoietin in the treatment of myelodysplastic syndromes. An interim reportM A Aloe Spiriti, M C Petti, R Latagliata, et al.
Blood|April 15, 1991
Molecular evaluation of response to all-trans-retinoic acid therapy in patients with acute promyelocytic leukemiaF Lo Coco, G Avvisati, D Diverio, et al.
British Journal of Haematology|July 1, 1990
High serum IL-2 levels are predictive of prolonged survival in multiple myelomaG Cimino, G Avvisati, S Amadori, et al.
Leukemia & Lymphoma|January 1, 1993
Is recombinant human erythropoietin treatment in myelodysplastic syndromes worthwhile?M A Aloe Spiriti, M C Petti, R Latagliata, et al.
British Journal of Haematology|August 1, 1991
Rearrangements of the RAR-alpha gene in acute promyelocytic leukaemia: correlations with morphology and immunophenotypeF Lo Coco, G Avvisati, D Diverio, et al.
Leukemia|April 1, 1993
Mitoxantrone, etoposide and intermediate-dose Ara-C (MEC): an effective regimen for poor risk acute myeloid leukemiaA Spadea, M C Petti, P Fazi, et al.
Pageof 15

Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
Blood|July 15, 1993
Polyclonal hematopoietic reconstitution in leukemia patients at remission after suppression of specific gene rearrangementsF Lo Coco, P G Pelicci, F D'Adamo, et al.
The New England Journal of Medicine|May 17, 1990
Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapyF Mandelli, G Avvisati, S Amadori, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 1998
The role of all-trans-retinoic acid (ATRA) treatment in newly-diagnosed acute promyelocytic leukemia patients aged > 60 yearsR Latagliata, G Avvisati, F Lo Coco, et al.
Haematologica|October 17, 2001
High dose of idarubicin-based regimen for diffuse large cell AIDS-related non-Hodgkin's lymphoma patients: a pilot studyR Gastaldi, P Martino, G Gentile, et al.
Haematologica|March 1, 1993
Recombinant human erythropoietin in the treatment of myelodysplastic syndromes. An interim reportM A Aloe Spiriti, M C Petti, R Latagliata, et al.
Blood|April 15, 1991
Molecular evaluation of response to all-trans-retinoic acid therapy in patients with acute promyelocytic leukemiaF Lo Coco, G Avvisati, D Diverio, et al.
British Journal of Haematology|July 1, 1990
High serum IL-2 levels are predictive of prolonged survival in multiple myelomaG Cimino, G Avvisati, S Amadori, et al.
Leukemia & Lymphoma|January 1, 1993
Is recombinant human erythropoietin treatment in myelodysplastic syndromes worthwhile?M A Aloe Spiriti, M C Petti, R Latagliata, et al.
British Journal of Haematology|August 1, 1991
Rearrangements of the RAR-alpha gene in acute promyelocytic leukaemia: correlations with morphology and immunophenotypeF Lo Coco, G Avvisati, D Diverio, et al.
Leukemia|April 1, 1993
Mitoxantrone, etoposide and intermediate-dose Ara-C (MEC): an effective regimen for poor risk acute myeloid leukemiaA Spadea, M C Petti, P Fazi, et al.
Pageof 15